Patent rights, a fillip for Natco Pharma Hindu Business Line In March this year Natco Pharma got the first-ever compulsory licence to manufacture sorafenib tosylate, a generic version of Bayer's expensive anti-cancer drug used in the treatment of liver and kidney cancer. Indian Patent Law allows grant of ... Bayer plea against Natco on cancer drug dismissed |
